2,8-Diacetylamino-1-tetralone → 2-Acetylamino-8-amino-5-methoxy-1-tetralone
반응식
[C:1]([NH:4][CH:5]1[CH2:14][CH2:13][C:12]2[C:7](=[C:8]([NH:17]C(=O)C)[CH:9]=[CH:10][C:11]=2[O:15][CH3:16])[C:6]1=[O:21])(=[O:3])[CH3:2].C(NC1CCC2C(=C(NC(=O)C)C=CC=2)C1=O)(=O)C>>[C:1]([NH:4][CH:5]1[CH2:14][CH2:13][C:12]2[C:7](=[C:8]([NH2:17])[CH:9]=[CH:10][C:11]=2[O:15][CH3:16])[C:6]1=[O:21])(=[O:3])[CH3:2]참가 물질
3
실험 절차
The same procedure as in Example 1-(4) was carried out, except that 200 mg of the compound prepared in (2) above was used instead of 2,8-diacetylamino-1-tetralone. Upon the post-treatment in the same manner as in Example 1-(4), 130 mg of the title compound was obtained.
출처 및 근거
- ORD 기록
- ord-9d0c6898fd18411ca8a4ae93f7682d3f
- 출처 데이터셋
- uspto-grants-2002_06
- 특허 번호
- US06407115B1
반응 노트
불러오는 중…